Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Lipinskas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Virology|June 15, 1978
The role of ATP in the biogenesis of vaccinia virus mRNA in vitroE Paoletti, B R Lipinskas
Journal of Virology|June 1, 1978
Soluble endoribonuclease activity from vaccinia virus: specific cleavage of virion-associated high-molecular-weight RNAE Paoletti, B R Lipinskas
Journal of Virology|January 1, 1980
Capped and polyadenylated low-molecular-weight RNA synthesized by vaccinia virus in vitroE Paoletti, B R Lipinskas, D Panicali
Science (New York, N.Y.)|September 6, 1985
Recombinant vaccinia virus: immunization against multiple pathogensM E Perkus, A Piccini, B R Lipinskas, et al.
Journal of Virology|May 1, 1982
Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotidesC Whitkop, B R Lipinskas, S Mercer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein DE Paoletti, B R Lipinskas, C Samsonoff, et al.
The Journal of Infectious Diseases|June 1, 1987
Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein DM Wachsman, L Aurelian, C C Smith, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Virology|June 15, 1978
The role of ATP in the biogenesis of vaccinia virus mRNA in vitroE Paoletti, B R Lipinskas
Journal of Virology|June 1, 1978
Soluble endoribonuclease activity from vaccinia virus: specific cleavage of virion-associated high-molecular-weight RNAE Paoletti, B R Lipinskas
Journal of Virology|January 1, 1980
Capped and polyadenylated low-molecular-weight RNA synthesized by vaccinia virus in vitroE Paoletti, B R Lipinskas, D Panicali
Science (New York, N.Y.)|September 6, 1985
Recombinant vaccinia virus: immunization against multiple pathogensM E Perkus, A Piccini, B R Lipinskas, et al.
Journal of Virology|May 1, 1982
Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotidesC Whitkop, B R Lipinskas, S Mercer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein DE Paoletti, B R Lipinskas, C Samsonoff, et al.
The Journal of Infectious Diseases|June 1, 1987
Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein DM Wachsman, L Aurelian, C C Smith, et al.
Pageof 1